Biotech & AI drug discoverySTAT — Biotech

Compass Pathways CEO: Psychedelics company will 'go slow before we go fast'

The CEO of Compass Pathways said the psychedelics company, whose psychedelic therapy is set for regulatory review this year, is prepared to "go slow before we go fast."

AI summary · generated only from source feed metadata; consult original

Source published2026-10-15T00:01:24+00:00

Published here2026-10-15T01:33:46+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/10/14/compass-pathways-psychedelics-stat-summit/

Original headline

Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.